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Comparison of Short-Term Immunosuppressive Therapy with 
Cyclosporine and FK 506 In Small-Bowel Transplantation 
K.K.W. Lee, M.J. Stangl, S. Todo, J.M. Langrehr, A. Hoffman, T.E. Starzl, and W.H. Schraut 
SINCE small-bowel transplantation was first described 
experimentally in the Iale 19505, control of graft 
rejection has been recognized as the primary obstacle to its 
successful clinical implementation. Early experimental 
and clinical studies demonstrated that immunosuppressive 
regimens based upon azathioprine, antilymphocyte globu-
lin, and corticosteroids were not sufficient to ensure long-
term recipient and graft survival. More recently long-term 
functional survival of intestinal allografts has been 
achieved with cyclosporine in a variety of experimental 
animal models and has led to renewed attempts at clinical 
small-bowel transplantation. Allhough long-term survival 
has been achieved in some instances, prevention of graft 
rejection remains a major problem. 
The neutral macrolide FK 506 has been shown on a 
molar basis to be a more potent inhibitor of in vivo and in 
vitro assays of immune function than cyclosporine. I It has 
also been shown to significantly delay rejection of kidney, 2 
heart,3 and liverA allografts in a number of different exper-
imental models. A rat model was therefore used to study 
the effectiveness of FK 506 in prolonging the survival of 
intestinal allografts and to compare its effectiveness with 
that observed for cyclosporine. 
MATERIALS AND METHODS 
One-stage orthotopic small-bowel transplantation utilizing sys-
temic venous out1low was performed in the fully allogeneic Browa 
Norway (BN. RTln) to Lewis (LEW. RTIl) rat strain combina-
tion using standard microsurgical techniques. Animals were al-
lowed water ad libitum and were restarted on nonnal laboratory 
diets on the second postoperative day. The general health. ap-
pearance. and behavior of the animals was closely monitored. 
Body weight was measured at frequent regular intervals. and 
routine biochemical studies were periodically perfonned on serum 
samples. With long-tenn surviving graft recipients. graft inspec-
tion and biopsy were performed via laparotomy. Autopsies and 
histopathologic: studies were performed on animals undergoilll 
rejection. 
Four experimental groups were prepared. In group I (N .. 6). 
transplantation was performed without immunosuppressive ther-
apy. In group II (N = II). graft recipients rec:eived cyclosporine 
(IS mglka dissolved in 10% IntraIipid) on days 0 to .. administered 
via intramusc:uIar injection. In group III (N - 17). cyclosporine 
was administered in the identical dose on days 0 to 6 and thea 
every other day until day 28. In group IV (N = 8). recipients 
received FK 506 (2 mg/kg dissolved in normal saline) on days 0 to 
4 administered via intramuscular injection. 
RESULTS 
Rats undergoing allogeneic transplantation without im-
munosuppressive therapy (group I) all developed acute 
rejection with a mean survival of 10.8 :t 1.4 days. Gnifts 
showed signs of acute rejection, which included distention 
and thinning of the bowel wall and inflammation of the 
graft mesentery. Histologic examination revealed acute 
mucosal destruction and a heavy cellular infiltrate. Group 
II rats receiving short courses of cyclosporine therapy 
began losing weight on approximately day 18 and had 
slightly prolonged mean survival (24.3 :t 3.9 days). These 
grafts showed evidence of less acute rejection, with filmy 
encapsulation of the grafts. less prominent ceUular infil-
tration of the grafts. and fibrous thickening of the bowel 
wall. 
All rats in groups III and IV receiving either FK 506 or 
extended courses of cyclosporine have remained alive for 
more than ISO days and free of signs of graft rejection. In 
both groups weight gain has been comparable to that 
observed in normal age-matched LEW rats; behavior and 
bowel function have appeared clinically normal. At lapa-
rotomy 6 months after transplantation. allografts in groups 
III and IV grossly appeared normal. Histologic examina-
tion of full-thickness graft biopsies appears normal with no 
signs of rejection; neither the liver nor the spleen show 
evidence of ongoing or prior graft-versus-host disease. 
Nutritional state as reflected by total protein, albumin. 
cholesterol. and triglyceride levels is normal in both 
groups. No evidence of cyclosporine- or FK S06-related 
toxicity has been observed. 
DISCUSSION 
The present study demonstrates that long-term recipient 
and graft survival can be achieved in this model of ortho-
topic small-bowel transplantation when very short courses 
of FK 506 are given. Similar long-term graft and recipient 
survival can be achieved with extended courses of cyclo-
sporine (group III). confirming an earlier report,.5 but when 
the same dosage of cyc1osporine is given for only five 
doses. long-tenn survival does not ensue as it does with 
FK S06. 
These results demonstrate that FK 506 is a potent 
immunosuppressive agent that may be more effective than 
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